Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder-Reference-Cited by-同舟云学术

Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder

Published:2023-07-19 Issue: Volume: Page:
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Joyce Vilija R.¹^ORCID,Oliva Elizabeth M.²^ORCID,Garcia Carla C.¹,Trafton Jodie³⁴,Asch Steven M.²⁵,Wagner Todd H.¹,Humphreys Keith²³^ORCID,Owens Douglas K.⁶,Bounthavong Mark¹

Affiliation:

1. VA Health Economics Resource Center, US Department of Veterans Affairs VA Palo Alto Health Care System Palo Alto CA USA

2. VA Center for Innovation to Implementation, US Department of Veterans Affairs VA Palo Alto Health Care System Palo Alto CA USA

3. Department of Psychiatry and Behavioral Sciences Stanford University Stanford CA USA

4. VA Program Evaluation and Resource Center Office of Mental Health and Suicide Prevention, VA Central Office, US Department of Veterans Affairs Palo Alto CA USA

5. Department of Medicine Stanford University Stanford CA USA

6. Stanford Health Policy, Department of Health Policy Stanford University Stanford CA USA

Abstract

AbstractAimsTo compare healthcare costs and use between United States (US) Veterans Health Administration (VHA) patients with opioid use disorder (OUD) who experienced an opioid overdose (OD cohort) and patients with OUD who did not experience an opioid overdose (non‐OD cohort).DesignThis is a retrospective cohort study of administrative and clinical data.SettingThe largest integrated national health‐care system is the US Veterans Health Administration's healthcare systems.ParticipantsWe included VHA patients diagnosed with OUD from October 1, 2017 through September 30, 2018. We identified the index date of overdose for patients who had an overdose. Our control group, which included patients with OUD who did not have an overdose, was randomly assigned an index date. A total of 66 513 patients with OUD were included for analysis (OD cohort: n = 1413; non‐OD cohort: n = 65 100).MeasurementsMonthly adjusted healthcare‐related costs and use in the year before and after the index date. We used generalized estimating equation models to compare patients with an opioid overdose and controls in a difference‐in‐differences framework.FindingsCompared with the non‐OD cohort, an opioid overdose was associated with an increase of $16 890 [95% confidence interval (CI) = $15 611–18 169; P < 0.001] in healthcare costs for an estimated $23.9 million in direct costs to VHA (95% CI = $22.1 million, $25.7 million) within the 30 days following overdose after adjusting for baseline characteristics. Inpatient costs ($13 515; 95% CI = $12 378–14 652; P < 0.001) reflected most of this increase. Inpatient days (+6.15 days; 95% CI, = 5.33–6.97; P < 0.001), inpatient admissions (+1.01 admissions; 95% CI = 0.93–1.10; P < 0.001) and outpatient visits (+1.59 visits; 95% CI = 1.34–1.84; P < 0.001) also increased in the month after opioid overdose. Within the overdose cohort, healthcare costs and use remained higher in the year after overdose compared with pre‐overdose trends.ConclusionsThe US Veterans Health Administration patients with opioid use disorder (OUD) who have experienced an opioid overdose have increased healthcare costs and use that remain significantly higher in the month and continuing through the year after overdose than OUD patients who have not experienced an overdose.

Funder

Rehabilitation Research and Development Service

National Institute on Drug Abuse

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.16289

Reference34 articles.

1. US Department of Health and Human Services.HHS acting secretary declares public health emergency to address national opioid crisis.HHS.gov. Available at:https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html(accessed 12 January 2022).

2. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission

3. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS publication no. PEP21‐07‐01‐003 NSDUH Series H‐56).2020. Available at:https://www.samhsa.gov/data/(accessed 25 January 2022).

4. Heroin use cannot be measured adequately with a general population survey

5. National Center for Health Statistics.VSRR provisional drug overdose death counts. Available at:https://data.cdc.gov/d/xkb8-kh2a(accessed 28 June 2022).